<?xml version="1.0" encoding="UTF-8"?><!-- generator="podbean/5.5" -->
<rss version="2.0"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
     xmlns:spotify="http://www.spotify.com/ns/rss"
     xmlns:podcast="https://podcastindex.org/namespace/1.0"
    xmlns:media="http://search.yahoo.com/mrss/">

<channel>
    <title>The Lancet Gastroenterology &amp; Hepatology in conversation with</title>
    <atom:link href="https://feed.podbean.com/lancetgastro/feed.xml" rel="self" type="application/rss+xml"/>
    <link>https://lancetgastro.podbean.com</link>
    <description><![CDATA[Hugh Thomas, Deputy Editor at The Lancet Gastroenterology &amp; Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.]]></description>
    <pubDate>Tue, 13 Oct 2026 23:30:00 +0000</pubDate>
    <generator>https://podbean.com/?v=5.5</generator>
    <language>en</language>
        <copyright>© 2026 The Lancet Group</copyright>
    <category>Health &amp; Fitness:Medicine</category>
    <ttl>1440</ttl>
    <itunes:type>episodic</itunes:type>
          <itunes:summary></itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
	<itunes:category text="Health &amp; Fitness">
		<itunes:category text="Medicine" />
	</itunes:category>
    <itunes:owner>
        <itunes:name>The Lancet Group</itunes:name>
            </itunes:owner>
    	<itunes:block>No</itunes:block>
	<itunes:explicit>false</itunes:explicit>
    <itunes:image href="https://pbcdn1.podbean.com/imglogo/image-logo/22224314/6n07yj6njf5qtd4iuh811cg6p7bi.jpg" />
    <image>
        <url>https://pbcdn1.podbean.com/imglogo/image-logo/22224314/6n07yj6njf5qtd4iuh811cg6p7bi.jpg</url>
        <title>The Lancet Gastroenterology &amp; Hepatology in conversation with</title>
        <link>https://lancetgastro.podbean.com</link>
        <width>144</width>
        <height>144</height>
    </image>
    <item>
        <title>Helen Jarvis on the role of primary care in response to the global liver disease syndemic</title>
        <itunes:title>Helen Jarvis on the role of primary care in response to the global liver disease syndemic</itunes:title>
        <link>https://lancetgastro.podbean.com/e/helen-jarvis-on-the-role-of-primary-care-in-response-to-the-global-liver-disease-syndemic/</link>
                    <comments>https://lancetgastro.podbean.com/e/helen-jarvis-on-the-role-of-primary-care-in-response-to-the-global-liver-disease-syndemic/#comments</comments>        <pubDate>Tue, 13 Oct 2026 23:30:00 +0000</pubDate>
        <guid isPermaLink="false">lancetgastro.podbean.com/258b9795-f633-346a-a61f-71bfb234f871</guid>
                                    <description><![CDATA[<p>How can we strengthen primary care-led liver health care? In this episode, we chat with Dr Helen Jarvis who led the recently published Commission on the role of primary care in response to the global liver disease syndemic.</p>
<p>Click here to read the full article: <a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00015-4/fulltext?dgcid=icw_podcast_acq-oct26_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00015-4/fulltext </a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>How can we strengthen primary care-led liver health care? In this episode, we chat with Dr Helen Jarvis who led the recently published Commission on the role of primary care in response to the global liver disease syndemic.</p>
<p>Click here to read the full article: <a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00015-4/fulltext?dgcid=icw_podcast_acq-oct26_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00015-4/fulltext </a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kc6g4hqitekbnfbe/primary-care-response-to-the-liver-disease-syndemic.mp3" length="29631081" type="audio/mpeg"/>
        <itunes:summary><![CDATA[How can we strengthen primary care-led liver health care? In this episode, we chat with Dr Helen Jarvis who led the recently published Commission on the role of primary care in response to the global liver disease syndemic.
Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00015-4/fulltext 
The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering.  Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall Podcast editing: Matteo Simonetti Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.  Find the best science for better lives at https://www.thelancet.com/Follow us today at...x.com/LancetGastroHepbsky.app/lancetgastrohep.bsky.social Linkedin.comInstagramFacebookyoutube.com/thelancettv]]></itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1233</itunes:duration>
                <itunes:episode>4</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <podcast:transcript url="https://mcdn.podbean.com/mf/web/zunk2ccca7xdgjmi/primary-care-response-to-the-liver-disease-syndemic.srt" type="application/srt" />    </item>
    <item>
        <title>Pere Ginès on long-term liver stiffness measurement as a screening tool for liver fibrosis</title>
        <itunes:title>Pere Ginès on long-term liver stiffness measurement as a screening tool for liver fibrosis</itunes:title>
        <link>https://lancetgastro.podbean.com/e/pere-gines-on-long-term-liver-stiffness-measurement-as-a-screening-tool-for-liver-fibrosis/</link>
                    <comments>https://lancetgastro.podbean.com/e/pere-gines-on-long-term-liver-stiffness-measurement-as-a-screening-tool-for-liver-fibrosis/#comments</comments>        <pubDate>Fri, 11 Sep 2026 12:45:00 +0000</pubDate>
        <guid isPermaLink="false">lancetgastro.podbean.com/23d22cc0-dead-3ce5-948f-2a95c633ad0a</guid>
                                    <description><![CDATA[<p>Could repeated liver stiffness measurement offer a practical approach to population-based liver fibrosis screening? In this episode, we speak with Pere Ginès about the LiverScreen study, which analysed changes in liver stiffness over time across three European cohorts and identified the risk factors associated with these changes.</p>
<p>Click here to read the full article:</p>
<p><a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00091-9/fulltext?dgcid=icw_podcast_acq-sept26_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00091-9/fulltext </a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Could repeated liver stiffness measurement offer a practical approach to population-based liver fibrosis screening? In this episode, we speak with Pere Ginès about the LiverScreen study, which analysed changes in liver stiffness over time across three European cohorts and identified the risk factors associated with these changes.</p>
<p>Click here to read the full article:</p>
<p><a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00091-9/fulltext?dgcid=icw_podcast_acq-sept26_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00091-9/fulltext </a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/stnnav6dhk4t3tn7/long-term-liver-stiffness-as-a-screening-for-fibrosis.mp3" length="27598218" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Could repeated liver stiffness measurement offer a practical approach to population-based liver fibrosis screening? In this episode, we speak with Pere Ginès about the LiverScreen study, which analysed changes in liver stiffness over time across three European cohorts and identified the risk factors associated with these changes.
Click here to read the full article:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00091-9/fulltext 
The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering.  Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall Podcast editing: Matteo Simonetti Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.  Find the best science for better lives at https://www.thelancet.com/Follow us today at...x.com/LancetGastroHepbsky.app/lancetgastrohep.bsky.social Linkedin.comInstagramFacebookyoutube.com/thelancettv]]></itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1149</itunes:duration>
                <itunes:episode>3</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <podcast:transcript url="https://mcdn.podbean.com/mf/web/tdd6nymri653rizp/long-term-liver-stiffness-as-a-screening-for-fibrosis.srt" type="application/srt" />    </item>
    <item>
        <title>Frank Ruemmele on a trial of cyclic exclusive enteral nutrition versus partial enteral nutrition to maintain remission in paediatric Crohn's disease</title>
        <itunes:title>Frank Ruemmele on a trial of cyclic exclusive enteral nutrition versus partial enteral nutrition to maintain remission in paediatric Crohn's disease</itunes:title>
        <link>https://lancetgastro.podbean.com/e/frank-ruemmele-on-a-trial-of-cyclic-exclusive-enteral-nutrition-versus-partial-enteral-nutrition-to-maintain-remission-in-paediatric-crohns-disease/</link>
                    <comments>https://lancetgastro.podbean.com/e/frank-ruemmele-on-a-trial-of-cyclic-exclusive-enteral-nutrition-versus-partial-enteral-nutrition-to-maintain-remission-in-paediatric-crohns-disease/#comments</comments>        <pubDate>Thu, 13 Aug 2026 12:06:00 +0000</pubDate>
        <guid isPermaLink="false">lancetgastro.podbean.com/c1572fcd-58cf-3e30-92b3-748c31bca213</guid>
                                    <description><![CDATA[<p>In children with Crohn’s disease who achieve remission through exclusive enteral nutrition, what's the optimal dietary therapy to maintain remission without the use of medication or surgery? Frank Ruemmele (Université Paris Cité) talks through the CD-Hope randomised controlled trial and its implications for clinical practice.</p>
<p>Click here to read the full article:</p>
<p><a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00262-6/fulltext?dgcid=icw_podcast_acq-aug-26_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00262-6/fulltext</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In children with Crohn’s disease who achieve remission through exclusive enteral nutrition, what's the optimal dietary therapy to maintain remission without the use of medication or surgery? Frank Ruemmele (Université Paris Cité) talks through the CD-Hope randomised controlled trial and its implications for clinical practice.</p>
<p>Click here to read the full article:</p>
<p><a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00262-6/fulltext?dgcid=icw_podcast_acq-aug-26_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00262-6/fulltext</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gp7neqg5jgt8jjia/cyclic-exclusive-enteral-nutrition-in-paediatric-Crohn-disease.mp3" length="32884349" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In children with Crohn’s disease who achieve remission through exclusive enteral nutrition, what's the optimal dietary therapy to maintain remission without the use of medication or surgery? Frank Ruemmele (Université Paris Cité) talks through the CD-Hope randomised controlled trial and its implications for clinical practice.
Click here to read the full article:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00262-6/fulltext
The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering.  Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall Podcast editing: Matteo Simonetti Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.  Find the best science for better lives at https://www.thelancet.com/Follow us today at...x.com/LancetGastroHepbsky.app/lancetgastrohep.bsky.social Linkedin.comInstagramFacebookyoutube.com/thelancettv]]></itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1369</itunes:duration>
                <itunes:episode>2</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <podcast:transcript url="https://mcdn.podbean.com/mf/web/iywg2ndexhh38bxv/cyclic-exclusive-enteral-nutrition-in-paediatric-Crohn-disease.srt" type="application/srt" />    </item>
    <item>
        <title>Aleksander Krag on the utility of PEth for subclassifying individuals at risk of steatotic liver disease</title>
        <itunes:title>Aleksander Krag on the utility of PEth for subclassifying individuals at risk of steatotic liver disease</itunes:title>
        <link>https://lancetgastro.podbean.com/e/aleksander-krag-on-the-utility-of-peth-for-subclassifying-individuals-at-risk-of-steatotic-liver-disease/</link>
                    <comments>https://lancetgastro.podbean.com/e/aleksander-krag-on-the-utility-of-peth-for-subclassifying-individuals-at-risk-of-steatotic-liver-disease/#comments</comments>        <pubDate>Mon, 23 Feb 2026 23:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-18711235</guid>
                                    <description><![CDATA[<p>Steatotic liver disease labels hinge on alcohol intake, but self-report is often inaccurate. In this episode, Aleksander Krag (Odense University Hospital) discusses a large Danish study using phosphatidylethanol (PEth), a direct blood biomarker of recent drinking, showing substantial underestimation and potential reclassification from MASLD to MetALD/ALD.</p>
<p>Click here to read the full article:</p>
<p><a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00187-6/fulltext?dgcid=tlcom_podcast_acq-february26_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00187-6/fulltext</a></p>
<p>Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the launch of, The Lancet Medical Imaging and Theranostics. </p>
<p>You can visit <a href='https://www.thelancet.com/medical-imaging-theranostics?dgcid=tlcom_podcast_lanmitlaunch_mm'>https://www.thelancet.com/medical-imaging-theranostics</a> to learn more.</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Steatotic liver disease labels hinge on alcohol intake, but self-report is often inaccurate. In this episode, Aleksander Krag (Odense University Hospital) discusses a large Danish study using phosphatidylethanol (PEth), a direct blood biomarker of recent drinking, showing substantial underestimation and potential reclassification from MASLD to MetALD/ALD.</p>
<p>Click here to read the full article:</p>
<p><a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00187-6/fulltext?dgcid=tlcom_podcast_acq-february26_langas'><b>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00187-6/fulltext</b></a></p>
<p>Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the launch of, <b>The Lancet Medical Imaging and Theranostics. </b></p>
<p>You can visit <a href='https://www.thelancet.com/medical-imaging-theranostics?dgcid=tlcom_podcast_lanmitlaunch_mm'><b>https://www.thelancet.com/medical-imaging-theranostics</b></a><b> </b>to learn more.</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/iotxb3tuv73oukwa/1728646_episodes_18711235-aleksander-krag-on-the-utility-of-peth-for-subclassifying-individuals-at-risk-of-steatotic-liver-disease.mp3" length="14680919" type="audio/mpeg"/>
        <itunes:summary>Steatotic liver disease labels hinge on alcohol intake, but self-report is often inaccurate. In this episode, Aleksander Krag (Odense University Hospital) discusses a large Danish study using phosphatidylethanol (PEth), a direct blood biomarker of recent drinking, showing substantial underestimation and potential reclassification from MASLD to MetALD/ALD. Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00187-6/fulltext Medical imaging an...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1220</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Dina Kao on a trial of lyophilised sterile faecal filtrate versus lyophilised conventional donor stool for recurrent Clostridiodes difficile infection</title>
        <itunes:title>Dina Kao on a trial of lyophilised sterile faecal filtrate versus lyophilised conventional donor stool for recurrent Clostridiodes difficile infection</itunes:title>
        <link>https://lancetgastro.podbean.com/e/dina-kao-on-a-trial-of-lyophilised-sterile-faecal-filtrate-versus-lyophilised-conventional-donor-stool-for-recurrent-clostridiodes-difficile-infection/</link>
                    <comments>https://lancetgastro.podbean.com/e/dina-kao-on-a-trial-of-lyophilised-sterile-faecal-filtrate-versus-lyophilised-conventional-donor-stool-for-recurrent-clostridiodes-difficile-infection/#comments</comments>        <pubDate>Fri, 28 Nov 2025 11:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-18229824</guid>
                                    <description><![CDATA[<p>Can bacteria-free, sterile faecal filtrate match conventional faecal microbiota transplantation for recurrent C difficile infection? Dina Kao (University of Alberta) unpacks a landmark multicentre trial that tested this hypothesis, and we discuss what it tells us about the role of living organisms in the therapeutic effects of microbiota-based therapies.</p>
<p>Click here to read the full article: <a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00190-6/fulltext?dgcid=tlcom_podcast_acq-november2-v2_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00190-6/fulltext</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Can bacteria-free, sterile faecal filtrate match conventional faecal microbiota transplantation for recurrent <em>C difficile</em> infection? Dina Kao (University of Alberta) unpacks a landmark multicentre trial that tested this hypothesis, and we discuss what it tells us about the role of living organisms in the therapeutic effects of microbiota-based therapies.</p>
<p>Click here to read the full article: <a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00190-6/fulltext?dgcid=tlcom_podcast_acq-november2-v2_langas'><b>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00190-6/fulltext</b></a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r9wqd0hqg3d3jxie/1728646_episodes_18229824-dina-kao-on-a-trial-of-lyophilised-sterile-faecal-filtrate-versus-lyophilised-conventional-donor-stool-for-recurrent-clostridiodes-difficile-infection.mp3" length="11499030" type="audio/mpeg"/>
        <itunes:summary>Can bacteria-free, sterile faecal filtrate match conventional faecal microbiota transplantation for recurrent C difficile infection? Dina Kao (University of Alberta) unpacks a landmark multicentre trial that tested this hypothesis, and we discuss what it tells us about the role of living organisms in the therapeutic effects of microbiota-based therapies. Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00190-6/fulltext Continue this conve...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>955</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Premysl Bercik on a double-blind crossover trial of gluten and wheat in IBS</title>
        <itunes:title>Premysl Bercik on a double-blind crossover trial of gluten and wheat in IBS</itunes:title>
        <link>https://lancetgastro.podbean.com/e/premysl-bercik-on-a-double-blind-crossover-trial-of-gluten-and-wheat-in-ibs/</link>
                    <comments>https://lancetgastro.podbean.com/e/premysl-bercik-on-a-double-blind-crossover-trial-of-gluten-and-wheat-in-ibs/#comments</comments>        <pubDate>Thu, 20 Nov 2025 14:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-18122957</guid>
                                    <description><![CDATA[<p>Do wheat or gluten trigger IBS symptoms? </p>
<p>We spoke to Premysl Bercik about a randomised, double-blind, sham-controlled crossover trial that challenged adults with IBS—who reported benefit from a gluten-free diet—with wheat, gluten, or a gluten-free sham to test symptom and behavioural responses.</p>
<p>Click here to read the full article: <a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00090-1/fulltext?dgcid=tlcom_podcast_acq-november-2025_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00090-1/fulltext</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Do wheat or gluten trigger IBS symptoms? </p>
<p>We spoke to Premysl Bercik about a randomised, double-blind, sham-controlled crossover trial that challenged adults with IBS—who reported benefit from a gluten-free diet—with wheat, gluten, or a gluten-free sham to test symptom and behavioural responses.</p>
<p>Click here to read the full article: <a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00090-1/fulltext?dgcid=tlcom_podcast_acq-november-2025_langas'><b>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00090-1/fulltext</b></a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3hfzhehaucrm155c/1728646_episodes_18122957-premysl-bercik-on-a-double-blind-crossover-trial-of-gluten-and-wheat-in-ibs.mp3" length="11814204" type="audio/mpeg"/>
        <itunes:summary>Do wheat or gluten trigger IBS symptoms?  We spoke to Premysl Bercik about a randomised, double-blind, sham-controlled crossover trial that challenged adults with IBS—who reported benefit from a gluten-free diet—with wheat, gluten, or a gluten-free sham to test symptom and behavioural responses. Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00090-1/fulltext Continue this conversation on social!  Follow us today at...  https://bsky...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>981</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Julia Mayerle on the validation of plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma</title>
        <itunes:title>Julia Mayerle on the validation of plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma</itunes:title>
        <link>https://lancetgastro.podbean.com/e/julia-mayerle-on-the-validation-of-plasma-multimetabolite-signatures-for-patients-at-risk-of-or-with-suspected-pancreatic-ductal-adenocarcinoma/</link>
                    <comments>https://lancetgastro.podbean.com/e/julia-mayerle-on-the-validation-of-plasma-multimetabolite-signatures-for-patients-at-risk-of-or-with-suspected-pancreatic-ductal-adenocarcinoma/#comments</comments>        <pubDate>Thu, 19 Jun 2025 12:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-17351280</guid>
                                    <description><![CDATA[<p>Can a multi-metabolite blood test improve early pancreatic cancer detection? We spoke to Julia Mayerle about the METAPAC study, which sought to validate the ability of plasma metabolic signatures to find resectable tumors and reduce unnecessary invasive procedures in high-risk patients.</p>
<p>Read the full article:</p>
<p><a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00056-1/fulltext?dgcid=buzzsprout_icw_podcast_June_25_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00056-1/fulltext?dgcid=buzzsprout_icw_podcast_June_25_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Can a multi-metabolite blood test improve early pancreatic cancer detection? We spoke to Julia Mayerle about the METAPAC study, which sought to validate the ability of plasma metabolic signatures to find resectable tumors and reduce unnecessary invasive procedures in high-risk patients.</p>
<p>Read the full article:</p>
<p><a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00056-1/fulltext?dgcid=buzzsprout_icw_podcast_June_25_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00056-1/fulltext?dgcid=buzzsprout_icw_podcast_June_25_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cxrifc8ajh2mb42g/1728646_episodes_17351280-julia-mayerle-on-the-validation-of-plasma-multimetabolite-signatures-for-patients-at-risk-of-or-with-suspected-pancreatic-ductal-adenocarcinoma.mp3" length="19372950" type="audio/mpeg"/>
        <itunes:summary>Can a multi-metabolite blood test improve early pancreatic cancer detection? We spoke to Julia Mayerle about the METAPAC study, which sought to validate the ability of plasma metabolic signatures to find resectable tumors and reduce unnecessary invasive procedures in high-risk patients. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00056-1/fulltext?dgcid=buzzsprout_icw_podcast_June_25_langas Continue this conversation on social!  Follow us today at....</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1612</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Salvatore Piano on the global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis</title>
        <itunes:title>Salvatore Piano on the global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis</itunes:title>
        <link>https://lancetgastro.podbean.com/e/salvatore-piano-on-the-global-epidemiology-of-acute-kidney-injury-in-hospitalised-patients-with-decompensated-cirrhosis/</link>
                    <comments>https://lancetgastro.podbean.com/e/salvatore-piano-on-the-global-epidemiology-of-acute-kidney-injury-in-hospitalised-patients-with-decompensated-cirrhosis/#comments</comments>        <pubDate>Wed, 09 Apr 2025 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-16910567</guid>
                                    <description><![CDATA[<p>How does acute kidney injury presentation and management differ globally for patients hospitalised with cirrhosis? </p>
<p>We spoke to Salvatore Piano, corresponding author of the landmark International Club of Ascites GLOBAL AKI study, about new data on regional variations in severity, phenotype, treatment, and outcomes across 5 continents.</p>
<p>Read the full article:</p>
<p><a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00006-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00006-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>How does acute kidney injury presentation and management differ globally for patients hospitalised with cirrhosis? </p>
<p>We spoke to Salvatore Piano, corresponding author of the landmark International Club of Ascites GLOBAL AKI study, about new data on regional variations in severity, phenotype, treatment, and outcomes across 5 continents.</p>
<p>Read the full article:</p>
<p><a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00006-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00006-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uhvv7q4bcwvr2s7p/1728646_episodes_16910567-salvatore-piano-on-the-global-epidemiology-of-acute-kidney-injury-in-hospitalised-patients-with-decompensated-cirrhosis.mp3" length="13772144" type="audio/mpeg"/>
        <itunes:summary>How does acute kidney injury presentation and management differ globally for patients hospitalised with cirrhosis?  We spoke to Salvatore Piano, corresponding author of the landmark International Club of Ascites GLOBAL AKI study, about new data on regional variations in severity, phenotype, treatment, and outcomes across 5 continents. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00006-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Cont...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1145</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>John Chia on the ASCOLT trial of adjuvant aspirin for colorectal cancer</title>
        <itunes:title>John Chia on the ASCOLT trial of adjuvant aspirin for colorectal cancer</itunes:title>
        <link>https://lancetgastro.podbean.com/e/john-chia-on-the-ascolt-trial-of-adjuvant-aspirin-for-colorectal-cancer/</link>
                    <comments>https://lancetgastro.podbean.com/e/john-chia-on-the-ascolt-trial-of-adjuvant-aspirin-for-colorectal-cancer/#comments</comments>        <pubDate>Thu, 06 Mar 2025 16:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-16744315</guid>
                                    <description><![CDATA[<p>John Chia discusses the results of the ASCOLT trial, which explored the effect of aspirin after completion of standard adjuvant therapy for patients with colorectal cancer.</p>
<p>Read the full article:</p>
<p><a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00387-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00387-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>John Chia discusses the results of the ASCOLT trial, which explored the effect of aspirin after completion of standard adjuvant therapy for patients with colorectal cancer.</p>
<p>Read the full article:</p>
<p><a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00387-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00387-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/w7no15r7wf6pbgxj/1728646_episodes_16744315-john-chia-on-the-ascolt-trial-of-adjuvant-aspirin-for-colorectal-cancer.mp3" length="9746004" type="audio/mpeg"/>
        <itunes:summary>John Chia discusses the results of the ASCOLT trial, which explored the effect of aspirin after completion of standard adjuvant therapy for patients with colorectal cancer. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00387-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://inst...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>809</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes</title>
        <itunes:title>Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes</itunes:title>
        <link>https://lancetgastro.podbean.com/e/hannes-hagstrom-on-screening-for-advanced-liver-fibrosis-alongside-retina-scanning-in-people-with-type-2-diabetes/</link>
                    <comments>https://lancetgastro.podbean.com/e/hannes-hagstrom-on-screening-for-advanced-liver-fibrosis-alongside-retina-scanning-in-people-with-type-2-diabetes/#comments</comments>        <pubDate>Fri, 10 Jan 2025 23:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-16388883</guid>
                                    <description><![CDATA[<p>Hannes Hagström discusses a study investigating the feasibility of screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00313-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00313-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hannes Hagström discusses a study investigating the feasibility of screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00313-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00313-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4nfvjd7xp48jh8d1/1728646_episodes_16388883-hannes-hagstrom-on-screening-for-advanced-liver-fibrosis-alongside-retina-scanning-in-people-with-type-2-diabetes.mp3" length="15428445" type="audio/mpeg"/>
        <itunes:summary>Hannes Hagström discusses a study investigating the feasibility of screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00313-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1283</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn’s disease small bowel strictures</title>
        <itunes:title>Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn’s disease small bowel strictures</itunes:title>
        <link>https://lancetgastro.podbean.com/e/cathy-lu-on-intestinal-ultrasound-for-assessing-and-monitoring-crohn-s-disease-small-bowel-strictures/</link>
                    <comments>https://lancetgastro.podbean.com/e/cathy-lu-on-intestinal-ultrasound-for-assessing-and-monitoring-crohn-s-disease-small-bowel-strictures/#comments</comments>        <pubDate>Thu, 12 Dec 2024 17:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-16266663</guid>
                                    <description><![CDATA[<p>Cathy Lu (University of Calgary) discusses a consensus statement on the use of intestinal ultrasound for assessing and monitoring small bowel strictures in Crohn's disease.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00265-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00265-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Cathy Lu (University of Calgary) discusses a consensus statement on the use of intestinal ultrasound for assessing and monitoring small bowel strictures in Crohn's disease.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00265-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00265-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/iozfd5k7tw46b7r9/1728646_episodes_16266663-cathy-lu-on-intestinal-ultrasound-for-assessing-and-monitoring-crohn-s-disease-small-bowel-strictures.mp3" length="8138377" type="audio/mpeg"/>
        <itunes:summary>Cathy Lu (University of Calgary) discusses a consensus statement on the use of intestinal ultrasound for assessing and monitoring small bowel strictures in Crohn's disease.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00265-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://ins...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>675</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis</title>
        <itunes:title>Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis</itunes:title>
        <link>https://lancetgastro.podbean.com/e/peter-de-cruz-on-the-predict-uc-trial-of-intensified-versus-standard-dose-infliximab-for-steroid-refractory-acute-severe-ulcerative-colitis/</link>
                    <comments>https://lancetgastro.podbean.com/e/peter-de-cruz-on-the-predict-uc-trial-of-intensified-versus-standard-dose-infliximab-for-steroid-refractory-acute-severe-ulcerative-colitis/#comments</comments>        <pubDate>Wed, 06 Nov 2024 15:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-16058609</guid>
                                    <description><![CDATA[<p>Peter De Cruz (University of Melbourne) discusses the PREDICT-UC trial of intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00200-0?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00200-0?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Peter De Cruz (University of Melbourne) discusses the PREDICT-UC trial of intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00200-0?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00200-0?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/weej6oo657qghxep/1728646_episodes_16058609-peter-de-cruz-on-the-predict-uc-trial-of-intensified-versus-standard-dose-infliximab-for-steroid-refractory-acute-severe-ulcerative-colitis.mp3" length="10623643" type="audio/mpeg"/>
        <itunes:summary>Peter De Cruz (University of Melbourne) discusses the PREDICT-UC trial of intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00200-0?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  h...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>882</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease</title>
        <itunes:title>Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease</itunes:title>
        <link>https://lancetgastro.podbean.com/e/shahida-din-and-beatriz-gros-on-the-harms-associated-with-receiving-placebo-in-trials-of-drugs-for-inflammatory-bowel-disease/</link>
                    <comments>https://lancetgastro.podbean.com/e/shahida-din-and-beatriz-gros-on-the-harms-associated-with-receiving-placebo-in-trials-of-drugs-for-inflammatory-bowel-disease/#comments</comments>        <pubDate>Fri, 01 Nov 2024 16:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-16017798</guid>
                                    <description><![CDATA[<p>Shahida Din (Western General Hospital, Edinburgh) and Beatriz Gros (Reina Sofía University Hospital, Cordoba) discuss two new papers on the harms associated with receiving placebo in induction and maintenance trials of biological therapies and small molecules in inflammatory bowel disease.

Read the full articles:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00264-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00264-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00233-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00233-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Shahida Din (Western General Hospital, Edinburgh) and Beatriz Gros (Reina Sofía University Hospital, Cordoba) discuss two new papers on the harms associated with receiving placebo in induction and maintenance trials of biological therapies and small molecules in inflammatory bowel disease.<br>
<br>
Read the full articles:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00264-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00264-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a><br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00233-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00233-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8j5pxissslxhy693/1728646_episodes_16017798-shahida-din-and-beatriz-gros-on-the-harms-associated-with-receiving-placebo-in-trials-of-drugs-for-inflammatory-bowel-disease.mp3" length="24701207" type="audio/mpeg"/>
        <itunes:summary>Shahida Din (Western General Hospital, Edinburgh) and Beatriz Gros (Reina Sofía University Hospital, Cordoba) discuss two new papers on the harms associated with receiving placebo in induction and maintenance trials of biological therapies and small molecules in inflammatory bowel disease.  Read the full articles: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00264-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas https://www.thelancet.com/journals/langas/article/PII...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2055</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer</title>
        <itunes:title>Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer</itunes:title>
        <link>https://lancetgastro.podbean.com/e/arndt-vogel-on-the-naliricc-trial-of-nanoliposomal-irinotecan-in-pretreated-advanced-biliary-tract-cancer/</link>
                    <comments>https://lancetgastro.podbean.com/e/arndt-vogel-on-the-naliricc-trial-of-nanoliposomal-irinotecan-in-pretreated-advanced-biliary-tract-cancer/#comments</comments>        <pubDate>Wed, 31 Jul 2024 14:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-15460606</guid>
                                    <description><![CDATA[<p>Arndt Vogel (Toronto General Hospital) discusses the NALIRICC trial of nanoliposomal irinotecan added to fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00119-5?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00119-5?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Arndt Vogel (Toronto General Hospital) discusses the NALIRICC trial of nanoliposomal irinotecan added to fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00119-5?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00119-5?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y2od5iee77605t3i/1728646_episodes_15460606-arndt-vogel-on-the-naliricc-trial-of-nanoliposomal-irinotecan-in-pretreated-advanced-biliary-tract-cancer.mp3" length="13277298" type="audio/mpeg"/>
        <itunes:summary>Arndt Vogel (Toronto General Hospital) discusses the NALIRICC trial of nanoliposomal irinotecan added to fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00119-5?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bs...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1103</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy</title>
        <itunes:title>Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy</itunes:title>
        <link>https://lancetgastro.podbean.com/e/nancy-baxter-on-the-duration-of-colorectal-cancer-risk-reduction-with-a-complete-colonoscopy/</link>
                    <comments>https://lancetgastro.podbean.com/e/nancy-baxter-on-the-duration-of-colorectal-cancer-risk-reduction-with-a-complete-colonoscopy/#comments</comments>        <pubDate>Mon, 01 Jul 2024 12:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-15340544</guid>
                                    <description><![CDATA[<p>Nancy Baxter (University of Melbourne) discusses a population-based study on the duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00084-0?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00084-0?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Nancy Baxter (University of Melbourne) discusses a population-based study on the duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00084-0?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00084-0?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/d10ynlsxsmk5v49y/1728646_episodes_15340544-nancy-baxter-on-the-duration-of-colorectal-cancer-risk-reduction-with-a-complete-colonoscopy.mp3" length="18097317" type="audio/mpeg"/>
        <itunes:summary>Nancy Baxter (University of Melbourne) discusses a population-based study on the duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00084-0?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://in...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1505</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS</title>
        <itunes:title>Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS</itunes:title>
        <link>https://lancetgastro.podbean.com/e/sanna-nybacka-and-magnus-simren-on-a-trial-of-low-fodmap-diets-versus-low-carbohydrate-diets-in-ibs/</link>
                    <comments>https://lancetgastro.podbean.com/e/sanna-nybacka-and-magnus-simren-on-a-trial-of-low-fodmap-diets-versus-low-carbohydrate-diets-in-ibs/#comments</comments>        <pubDate>Fri, 17 May 2024 11:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-15072879</guid>
                                    <description><![CDATA[<p>Sanna Nybacka and Magnus Simrén (University of Gothenburg) discuss the CARIBS randomised controlled trial of a low FODMAP diet versus a low-carbohydrate diet versus pharmacological treatment in IBS.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00045-1/fulltext?dgcid=buzzsprout_tlv_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00045-1/fulltext?dgcid=buzzsprout_tlv_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Sanna Nybacka and Magnus Simrén (University of Gothenburg) discuss the CARIBS randomised controlled trial of a low FODMAP diet versus a low-carbohydrate diet versus pharmacological treatment in IBS.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00045-1/fulltext?dgcid=buzzsprout_tlv_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00045-1/fulltext?dgcid=buzzsprout_tlv_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/62694i558g8fu02y/1728646_episodes_15072879-sanna-nybacka-and-magnus-simren-on-a-trial-of-low-fodmap-diets-versus-low-carbohydrate-diets-in-ibs.mp3" length="16788281" type="audio/mpeg"/>
        <itunes:summary>Sanna Nybacka and Magnus Simrén (University of Gothenburg) discuss the CARIBS randomised controlled trial of a low FODMAP diet versus a low-carbohydrate diet versus pharmacological treatment in IBS.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00045-1/fulltext?dgcid=buzzsprout_tlv_podcast_generic_langas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/compa...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1396</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn’s disease</title>
        <itunes:title>Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn’s disease</itunes:title>
        <link>https://lancetgastro.podbean.com/e/nuru-noor-on-the-profile-trial-of-biomarker-stratified-treatment-in-newly-diagnosed-crohn-s-disease/</link>
                    <comments>https://lancetgastro.podbean.com/e/nuru-noor-on-the-profile-trial-of-biomarker-stratified-treatment-in-newly-diagnosed-crohn-s-disease/#comments</comments>        <pubDate>Tue, 07 May 2024 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-15023557</guid>
                                    <description><![CDATA[<p>Nuru Noor (University of Cambridge) discusses the PROFILE trial of biomarker-stratified treatment strategies in people with newly diagnosed Crohn's disease.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00034-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00034-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Nuru Noor (University of Cambridge) discusses the PROFILE trial of biomarker-stratified treatment strategies in people with newly diagnosed Crohn's disease.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00034-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00034-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3ly25wn6xo2ple4h/1728646_episodes_15023557-nuru-noor-on-the-profile-trial-of-biomarker-stratified-treatment-in-newly-diagnosed-crohn-s-disease.mp3" length="14372972" type="audio/mpeg"/>
        <itunes:summary>Nuru Noor (University of Cambridge) discusses the PROFILE trial of biomarker-stratified treatment strategies in people with newly diagnosed Crohn's disease.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00034-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com/thela...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1195</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa</title>
        <itunes:title>Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa</itunes:title>
        <link>https://lancetgastro.podbean.com/e/yusuke-shimakawa-on-a-simple-score-for-hepatitis-b-treatment-eligibility-in-africa/</link>
                    <comments>https://lancetgastro.podbean.com/e/yusuke-shimakawa-on-a-simple-score-for-hepatitis-b-treatment-eligibility-in-africa/#comments</comments>        <pubDate>Mon, 22 Apr 2024 09:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-14931806</guid>
                                    <description><![CDATA[<p>Yusuke Shimakawa (Institut Pasteur) discusses the development and evaluation of a simple score for hepatitis B treatment eligibility in Africa.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00449-1?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00449-1?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Yusuke Shimakawa (Institut Pasteur) discusses the development and evaluation of a simple score for hepatitis B treatment eligibility in Africa.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00449-1?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00449-1?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uh9th2bbrdyfi7ws/1728646_episodes_14931806-yusuke-shimakawa-on-a-simple-score-for-hepatitis-b-treatment-eligibility-in-africa.mp3" length="15076170" type="audio/mpeg"/>
        <itunes:summary>Yusuke Shimakawa (Institut Pasteur) discusses the development and evaluation of a simple score for hepatitis B treatment eligibility in Africa.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00449-1?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com/thelancetgroup  https://fac...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1254</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake</title>
        <itunes:title>Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake</itunes:title>
        <link>https://lancetgastro.podbean.com/e/mads-israelsen-on-validating-the-new-steatotic-liver-disease-nomenclature-in-people-with-excessive-alcohol-intake/</link>
                    <comments>https://lancetgastro.podbean.com/e/mads-israelsen-on-validating-the-new-steatotic-liver-disease-nomenclature-in-people-with-excessive-alcohol-intake/#comments</comments>        <pubDate>Tue, 12 Mar 2024 15:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-14676827</guid>
                                    <description><![CDATA[<p>Mads Israelsen (Odense University Hospital) discusses a study to validate the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00443-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00443-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Mads Israelsen (Odense University Hospital) discusses a study to validate the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00443-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00443-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/w5gatriujx0chz0n/1728646_episodes_14676827-mads-israelsen-on-validating-the-new-steatotic-liver-disease-nomenclature-in-people-with-excessive-alcohol-intake.mp3" length="12014969" type="audio/mpeg"/>
        <itunes:summary>Mads Israelsen (Odense University Hospital) discusses a study to validate the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00443-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https:...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>999</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity</title>
        <itunes:title>Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity</itunes:title>
        <link>https://lancetgastro.podbean.com/e/louise-dye-on-the-role-of-expectancy-and-gluten-in-non-coeliac-gluten-sensitivity/</link>
                    <comments>https://lancetgastro.podbean.com/e/louise-dye-on-the-role-of-expectancy-and-gluten-in-non-coeliac-gluten-sensitivity/#comments</comments>        <pubDate>Fri, 01 Mar 2024 15:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-14608219</guid>
                                    <description><![CDATA[<p>Louise Dye (University of Leeds) discusses a trial exploring the role of expectancy and gluten ingestion on symptoms in people with non-coeliac gluten sensitivity.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00317-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00317-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Louise Dye (University of Leeds) discusses a trial exploring the role of expectancy and gluten ingestion on symptoms in people with non-coeliac gluten sensitivity.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00317-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00317-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/a71zy50rpavbfxtq/1728646_episodes_14608219-louise-dye-on-the-role-of-expectancy-and-gluten-in-non-coeliac-gluten-sensitivity.mp3" length="16814748" type="audio/mpeg"/>
        <itunes:summary>Louise Dye (University of Leeds) discusses a trial exploring the role of expectancy and gluten ingestion on symptoms in people with non-coeliac gluten sensitivity.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00317-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.co...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1399</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region</title>
        <itunes:title>Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region</itunes:title>
        <link>https://lancetgastro.podbean.com/e/tzu-chan-hong-on-the-primary-antibiotic-resistance-of-helicobacter-pylori-in-the-asia-pacific-region/</link>
                    <comments>https://lancetgastro.podbean.com/e/tzu-chan-hong-on-the-primary-antibiotic-resistance-of-helicobacter-pylori-in-the-asia-pacific-region/#comments</comments>        <pubDate>Tue, 19 Dec 2023 11:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-14172839</guid>
                                    <description><![CDATA[<p>Tzu-Chan Hong (National Taiwan University Cancer Centre) discusses a systematic review and meta-analysis on primary antibiotic resistance of Helicobacter pylori between 1990 and 2022 in the Asia-Pacific region.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00281-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00281-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Tzu-Chan Hong (National Taiwan University Cancer Centre) discusses a systematic review and meta-analysis on primary antibiotic resistance of Helicobacter pylori between 1990 and 2022 in the Asia-Pacific region.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00281-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00281-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/foy5fj5l52rrmupp/1728646_episodes_14172839-tzu-chan-hong-on-the-primary-antibiotic-resistance-of-helicobacter-pylori-in-the-asia-pacific-region.mp3" length="10594529" type="audio/mpeg"/>
        <itunes:summary>Tzu-Chan Hong (National Taiwan University Cancer Centre) discusses a systematic review and meta-analysis on primary antibiotic resistance of Helicobacter pylori between 1990 and 2022 in the Asia-Pacific region.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00281-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linked...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>880</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy</title>
        <itunes:title>Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy</itunes:title>
        <link>https://lancetgastro.podbean.com/e/sarah-moen-on-metachronous-colorectal-cancer-risk-according-to-lynch-syndrome-pathogenic-variant-after-colectomy/</link>
                    <comments>https://lancetgastro.podbean.com/e/sarah-moen-on-metachronous-colorectal-cancer-risk-according-to-lynch-syndrome-pathogenic-variant-after-colectomy/#comments</comments>        <pubDate>Wed, 29 Nov 2023 16:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-14056722</guid>
                                    <description><![CDATA[<p>Sarah Moen (Erasmus University Medical Center) discusses a retrospective cohort study examining the risk of metachronous colorectal cancer after partial or extensive colectomy in carriers of different pathogenic Lynch syndrome variants.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00228-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00228-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Sarah Moen (Erasmus University Medical Center) discusses a retrospective cohort study examining the risk of metachronous colorectal cancer after partial or extensive colectomy in carriers of different pathogenic Lynch syndrome variants.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00228-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00228-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/o011ns1fv519rf13/1728646_episodes_14056722-sarah-moen-on-metachronous-colorectal-cancer-risk-according-to-lynch-syndrome-pathogenic-variant-after-colectomy.mp3" length="10659742" type="audio/mpeg"/>
        <itunes:summary>Sarah Moen (Erasmus University Medical Center) discusses a retrospective cohort study examining the risk of metachronous colorectal cancer after partial or extensive colectomy in carriers of different pathogenic Lynch syndrome variants.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00228-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky....</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>885</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease</title>
        <itunes:title>Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease</itunes:title>
        <link>https://lancetgastro.podbean.com/e/anna-emilie-kann-on-the-causes-of-mortality-in-patients-with-alcohol-related-liver-disease/</link>
                    <comments>https://lancetgastro.podbean.com/e/anna-emilie-kann-on-the-causes-of-mortality-in-patients-with-alcohol-related-liver-disease/#comments</comments>        <pubDate>Thu, 12 Oct 2023 16:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-13766613</guid>
                                    <description><![CDATA[<p>Anna Emilie Kann  (Zealand University Hospital, Denmark) discusses a population-based study done in Denmark exploring the causes of mortality in patients with alcohol-related liver disease.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00192-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00192-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Anna Emilie Kann  (Zealand University Hospital, Denmark) discusses a population-based study done in Denmark exploring the causes of mortality in patients with alcohol-related liver disease.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00192-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00192-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j10635i6ztpl6ymd/1728646_episodes_13766613-anna-emilie-kann-on-the-causes-of-mortality-in-patients-with-alcohol-related-liver-disease.mp3" length="11787610" type="audio/mpeg"/>
        <itunes:summary>Anna Emilie Kann  (Zealand University Hospital, Denmark) discusses a population-based study done in Denmark exploring the causes of mortality in patients with alcohol-related liver disease.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00192-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/l...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>979</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction</title>
        <itunes:title>Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction</itunes:title>
        <link>https://lancetgastro.podbean.com/e/robert-krouse-on-surgical-versus-non-surgical-management-of-malignant-bowel-obstruction/</link>
                    <comments>https://lancetgastro.podbean.com/e/robert-krouse-on-surgical-versus-non-surgical-management-of-malignant-bowel-obstruction/#comments</comments>        <pubDate>Wed, 13 Sep 2023 10:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-13583286</guid>
                                    <description><![CDATA[<p>Robert Krouse (University of Pennsylvania) discusses the pragmatic S1316 trial of surgical versus non-surgical management for patients with malignant small bowel obstruction.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00191-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00191-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Robert Krouse (University of Pennsylvania) discusses the pragmatic S1316 trial of surgical versus non-surgical management for patients with malignant small bowel obstruction.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00191-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00191-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tpa2hrr92abyz229/1728646_episodes_13583286-robert-krouse-on-surgical-versus-non-surgical-management-of-malignant-bowel-obstruction.mp3" length="11922392" type="audio/mpeg"/>
        <itunes:summary>Robert Krouse (University of Pennsylvania) discusses the pragmatic S1316 trial of surgical versus non-surgical management for patients with malignant small bowel obstruction.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00191-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://i...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>991</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis</title>
        <itunes:title>Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis</itunes:title>
        <link>https://lancetgastro.podbean.com/e/marc-rothenberg-on-a-trial-of-benralizumab-in-eosinophilic-gastritis/</link>
                    <comments>https://lancetgastro.podbean.com/e/marc-rothenberg-on-a-trial-of-benralizumab-in-eosinophilic-gastritis/#comments</comments>        <pubDate>Thu, 10 Aug 2023 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-13383469</guid>
                                    <description><![CDATA[<p>Marc Rothenberg (University of Cincinnati College of Medicine) discusses a new trial assessing the efficacy and safety of benralizumab in patients with eosinophilic gastritis, and how the surprising findings might change our understanding of eosinophilic gastrointestinal diseases.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00145-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00145-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Marc Rothenberg (University of Cincinnati College of Medicine) discusses a new trial assessing the efficacy and safety of benralizumab in patients with eosinophilic gastritis, and how the surprising findings might change our understanding of eosinophilic gastrointestinal diseases.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00145-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00145-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/1t9b9543l2dye4dq/1728646_episodes_13383469-marc-rothenberg-on-a-trial-of-benralizumab-in-eosinophilic-gastritis.mp3" length="10457814" type="audio/mpeg"/>
        <itunes:summary>Marc Rothenberg (University of Cincinnati College of Medicine) discusses a new trial assessing the efficacy and safety of benralizumab in patients with eosinophilic gastritis, and how the surprising findings might change our understanding of eosinophilic gastrointestinal diseases.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00145-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social!  Follow us today at...  h...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>869</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease</title>
        <itunes:title>Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease</itunes:title>
        <link>https://lancetgastro.podbean.com/e/michael-pavlides-on-non-invasive-tests-for-predicting-clinical-outcomes-in-non-alcoholic-fatty-liver-disease/</link>
                    <comments>https://lancetgastro.podbean.com/e/michael-pavlides-on-non-invasive-tests-for-predicting-clinical-outcomes-in-non-alcoholic-fatty-liver-disease/#comments</comments>        <pubDate>Wed, 12 Jul 2023 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-13209201</guid>
                                    <description><![CDATA[<p>Michael Pavlides (University of Oxford) discusses work by the LITMUS Consortium on the prognostic performance of non-invasive tests in patients with non-alcoholic fatty liver disease.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00017-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00017-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Michael Pavlides (University of Oxford) discusses work by the LITMUS Consortium on the prognostic performance of non-invasive tests in patients with non-alcoholic fatty liver disease.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00017-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00017-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/semq9ipqbv6f4ovr/1728646_episodes_13209201-michael-pavlides-on-non-invasive-tests-for-predicting-clinical-outcomes-in-non-alcoholic-fatty-liver-disease.mp3" length="12763116" type="audio/mpeg"/>
        <itunes:summary>Michael Pavlides (University of Oxford) discusses work by the LITMUS Consortium on the prognostic performance of non-invasive tests in patients with non-alcoholic fatty liver disease.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00017-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  ...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1061</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis</title>
        <itunes:title>Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis</itunes:title>
        <link>https://lancetgastro.podbean.com/e/jasmohan-bajaj-on-global-disparities-in-mortality-and-liver-transplantation-in-hospitalised-patients-with-cirrhosis/</link>
                    <comments>https://lancetgastro.podbean.com/e/jasmohan-bajaj-on-global-disparities-in-mortality-and-liver-transplantation-in-hospitalised-patients-with-cirrhosis/#comments</comments>        <pubDate>Wed, 07 Jun 2023 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-12995752</guid>
                                    <description><![CDATA[<p>Jasmohan Bajaj (Virginia Commonwealth University and Central Virginia Veterans Healthcare System, Richmond, VA, USA), on behalf of the CLEARED Consortium, discusses a prospective observational cohort study examining global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00098-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00098-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Jasmohan Bajaj (Virginia Commonwealth University and Central Virginia Veterans Healthcare System, Richmond, VA, USA), on behalf of the CLEARED Consortium, discusses a prospective observational cohort study examining global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00098-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00098-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/w47mb69cyegb2dg2/1728646_episodes_12995752-jasmohan-bajaj-on-global-disparities-in-mortality-and-liver-transplantation-in-hospitalised-patients-with-cirrhosis.mp3" length="9252830" type="audio/mpeg"/>
        <itunes:summary>Jasmohan Bajaj (Virginia Commonwealth University and Central Virginia Veterans Healthcare System, Richmond, VA, USA), on behalf of the CLEARED Consortium, discusses a prospective observational cohort study examining global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00098-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on ...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>768</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Adelina Artenie on the incidence of HIV and HCV in people who inject drugs</title>
        <itunes:title>Adelina Artenie on the incidence of HIV and HCV in people who inject drugs</itunes:title>
        <link>https://lancetgastro.podbean.com/e/adelina-artenie-on-the-incidence-of-hiv-and-hcv-in-people-who-inject-drugs/</link>
                    <comments>https://lancetgastro.podbean.com/e/adelina-artenie-on-the-incidence-of-hiv-and-hcv-in-people-who-inject-drugs/#comments</comments>        <pubDate>Wed, 10 May 2023 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-12783690</guid>
                                    <description><![CDATA[<p>Adelina Artenie (University of Bristol, UK) discusses a systematic review and meta-analysis exploring the incidence of HIV and HCV among people who inject drugs, and associations with age and sex or gender. 

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00018-3/fulltext?dgcid=buzzsprout_icw_podcast_langas_lancet'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00018-3/fulltext?dgcid=buzzsprout_icw_podcast_langas_lancet</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Adelina Artenie (University of Bristol, UK) discusses a systematic review and meta-analysis exploring the incidence of HIV and HCV among people who inject drugs, and associations with age and sex or gender. <br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00018-3/fulltext?dgcid=buzzsprout_icw_podcast_langas_lancet'>https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00018-3/fulltext?dgcid=buzzsprout_icw_podcast_langas_lancet</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bp51zxbd4hp2v0eh/1728646_episodes_12783690-adelina-artenie-on-the-incidence-of-hiv-and-hcv-in-people-who-inject-drugs.mp3" length="12460974" type="audio/mpeg"/>
        <itunes:summary>Adelina Artenie (University of Bristol, UK) discusses a systematic review and meta-analysis exploring the incidence of HIV and HCV among people who inject drugs, and associations with age and sex or gender.   Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00018-3/fulltext?dgcid=buzzsprout_icw_podcast_langas_lancet Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.c...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1035</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Johan Burisch on the costs of inflammatory bowel disease in high-income settings</title>
        <itunes:title>Johan Burisch on the costs of inflammatory bowel disease in high-income settings</itunes:title>
        <link>https://lancetgastro.podbean.com/e/johan-burisch-on-the-costs-of-inflammatory-bowel-disease-in-high-income-settings/</link>
                    <comments>https://lancetgastro.podbean.com/e/johan-burisch-on-the-costs-of-inflammatory-bowel-disease-in-high-income-settings/#comments</comments>        <pubDate>Wed, 12 Apr 2023 10:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-12635774</guid>
                                    <description><![CDATA[<p>Johan Burisch (Copenhagen University Hospital, Denmark) discusses the findings and recommendations of The Lancet Gastroenterology &amp; Hepatology Commission on the cost of inflammatory bowel disease in high-income settings.

Read the Commission here:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00003-1/fulltext'>The cost of inflammatory bowel disease in high-income settings</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Johan Burisch (Copenhagen University Hospital, Denmark) discusses the findings and recommendations of <em>The Lancet Gastroenterology &amp; Hepatology</em> Commission on the cost of inflammatory bowel disease in high-income settings.<br>
<br>
Read the Commission here:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00003-1/fulltext'>The cost of inflammatory bowel disease in high-income settings</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/n21y95olqnizrzf8/1728646_episodes_12635774-johan-burisch-on-the-costs-of-inflammatory-bowel-disease-in-high-income-settings.mp3" length="14435357" type="audio/mpeg"/>
        <itunes:summary>Johan Burisch (Copenhagen University Hospital, Denmark) discusses the findings and recommendations of The Lancet Gastroenterology &amp;amp;amp; Hepatology Commission on the cost of inflammatory bowel disease in high-income settings.  Read the Commission here: The cost of inflammatory bowel disease in high-income settings Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1200</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease</title>
        <itunes:title>Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease</itunes:title>
        <link>https://lancetgastro.podbean.com/e/edouard-louis-on-the-spare-trial-of-infliximab-or-immunosuppressant-withdrawal-in-crohn-s-disease/</link>
                    <comments>https://lancetgastro.podbean.com/e/edouard-louis-on-the-spare-trial-of-infliximab-or-immunosuppressant-withdrawal-in-crohn-s-disease/#comments</comments>        <pubDate>Wed, 08 Feb 2023 23:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-12210026</guid>
                                    <description><![CDATA[<p>Edouard Louis (University Hospital CHU of Liège) discusses the SPARE randomised controlled trial of infliximab or concomitant immunosuppressant withdrawal in patients with Crohn’s disease.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00385-5/fulltext'>Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE)</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Edouard Louis (University Hospital CHU of Liège) discusses the SPARE randomised controlled trial of infliximab or concomitant immunosuppressant withdrawal in patients with Crohn’s disease.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00385-5/fulltext'>Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE)</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7vl62r93pecrz7xc/1728646_episodes_12210026-edouard-louis-on-the-spare-trial-of-infliximab-or-immunosuppressant-withdrawal-in-crohn-s-disease.mp3" length="15515096" type="audio/mpeg"/>
        <itunes:summary>Edouard Louis (University Hospital CHU of Liège) discusses the SPARE randomised controlled trial of infliximab or concomitant immunosuppressant withdrawal in patients with Crohn’s disease.  Read the full article: Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE) Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langa...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1290</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancer</title>
        <itunes:title>Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancer</itunes:title>
        <link>https://lancetgastro.podbean.com/e/paula-ghaneh-on-the-espac5-trial-of-neoadjuvant-therapy-in-borderline-resectable-pancreatic-cancer/</link>
                    <comments>https://lancetgastro.podbean.com/e/paula-ghaneh-on-the-espac5-trial-of-neoadjuvant-therapy-in-borderline-resectable-pancreatic-cancer/#comments</comments>        <pubDate>Mon, 23 Jan 2023 15:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-12100746</guid>
                                    <description><![CDATA[<p>Paula Ghaneh (University of Liverpool) discusses the ESPAC5 randomised controlled trial of short-course neoadjuvant therapy compared with immediate surgery for patients with borderline resectable pancreatic ductal adenocarcinoma. 

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00348-X/fulltext'>Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5)</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Paula Ghaneh (University of Liverpool) discusses the ESPAC5 randomised controlled trial of short-course neoadjuvant therapy compared with immediate surgery for patients with borderline resectable pancreatic ductal adenocarcinoma. <br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00348-X/fulltext'>Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5)</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e5nkatx63rt6koqz/1728646_episodes_12100746-paula-ghaneh-on-the-espac5-trial-of-neoadjuvant-therapy-in-borderline-resectable-pancreatic-cancer.mp3" length="14684880" type="audio/mpeg"/>
        <itunes:summary>Paula Ghaneh (University of Liverpool) discusses the ESPAC5 randomised controlled trial of short-course neoadjuvant therapy compared with immediate surgery for patients with borderline resectable pancreatic ductal adenocarcinoma.   Read the full article: Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5) Continue this conversation on social!  Follow us today ...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1220</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Dan Turner on vedolizumab in children with IBD</title>
        <itunes:title>Dan Turner on vedolizumab in children with IBD</itunes:title>
        <link>https://lancetgastro.podbean.com/e/dan-turner-on-vedolizumab-in-children-with-ibd/</link>
                    <comments>https://lancetgastro.podbean.com/e/dan-turner-on-vedolizumab-in-children-with-ibd/#comments</comments>        <pubDate>Fri, 06 Jan 2023 10:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-11991237</guid>
                                    <description><![CDATA[<p>Dan Turner (Shaare Zedek Medical Center) discusses the VEDOKIDS study on the safety, effectiveness, and dosing of vedolizumab in children with IBD.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00307-7/fulltext'>Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS)</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Dan Turner (Shaare Zedek Medical Center) discusses the VEDOKIDS study on the safety, effectiveness, and dosing of vedolizumab in children with IBD.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00307-7/fulltext'>Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS)</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/07grzjdewur8td5d/1728646_episodes_11991237-dan-turner-on-vedolizumab-in-children-with-ibd.mp3" length="10737897" type="audio/mpeg"/>
        <itunes:summary>Dan Turner (Shaare Zedek Medical Center) discusses the VEDOKIDS study on the safety, effectiveness, and dosing of vedolizumab in children with IBD.  Read the full article: Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS) Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com/thelancetgroup  https://faceb...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>891</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection</title>
        <itunes:title>Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection</itunes:title>
        <link>https://lancetgastro.podbean.com/e/simon-baunwall-on-faecal-microbiota-transplantation-for-first-or-second-clostridioides-difficile-infection/</link>
                    <comments>https://lancetgastro.podbean.com/e/simon-baunwall-on-faecal-microbiota-transplantation-for-first-or-second-clostridioides-difficile-infection/#comments</comments>        <pubDate>Wed, 09 Nov 2022 23:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-11654372</guid>
                                    <description><![CDATA[<p>Simon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faecal microbiota transplantation for first or second Clostridioides difficile infection.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00276-X/fulltext'>Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT)</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Simon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faecal microbiota transplantation for first or second Clostridioides difficile infection.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00276-X/fulltext'>Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT)</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zdzcaeoqtjtd8j3t/1728646_episodes_11654372-simon-baunwall-on-faecal-microbiota-transplantation-for-first-or-second-clostridioides-difficile-infection.mp3" length="11093806" type="audio/mpeg"/>
        <itunes:summary>Simon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faecal microbiota transplantation for first or second Clostridioides difficile infection.  Read the full article: Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT) Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https:/...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>921</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>James Alexander on immune responses to COVID-19 vaccination in patients with IBD</title>
        <itunes:title>James Alexander on immune responses to COVID-19 vaccination in patients with IBD</itunes:title>
        <link>https://lancetgastro.podbean.com/e/james-alexander-on-immune-responses-to-covid-19-vaccination-in-patients-with-ibd/</link>
                    <comments>https://lancetgastro.podbean.com/e/james-alexander-on-immune-responses-to-covid-19-vaccination-in-patients-with-ibd/#comments</comments>        <pubDate>Wed, 05 Oct 2022 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-11442875</guid>
                                    <description><![CDATA[<p>James Alexander (Imperial College London) discusses the latest findings from the VIP case-control study, which is investigating COVID-19 vaccine immune responses in immunosuppressed patients with inflammatory bowel disease.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00274-6/fulltext'>COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP)</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>James Alexander (Imperial College London) discusses the latest findings from the VIP case-control study, which is investigating COVID-19 vaccine immune responses in immunosuppressed patients with inflammatory bowel disease.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00274-6/fulltext'>COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP)</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7ez2fopn77d9i9n7/1728646_episodes_11442875-james-alexander-on-immune-responses-to-covid-19-vaccination-in-patients-with-ibd.mp3" length="9973946" type="audio/mpeg"/>
        <itunes:summary>James Alexander (Imperial College London) discusses the latest findings from the VIP case-control study, which is investigating COVID-19 vaccine immune responses in immunosuppressed patients with inflammatory bowel disease.  Read the full article: COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP) Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastr...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>828</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Filip Knop on liraglutide for bile acid diarrhoea</title>
        <itunes:title>Filip Knop on liraglutide for bile acid diarrhoea</itunes:title>
        <link>https://lancetgastro.podbean.com/e/filip-knop-on-liraglutide-for-bile-acid-diarrhoea/</link>
                    <comments>https://lancetgastro.podbean.com/e/filip-knop-on-liraglutide-for-bile-acid-diarrhoea/#comments</comments>        <pubDate>Wed, 07 Sep 2022 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-11237448</guid>
                                    <description><![CDATA[<p>Filip Knop (University of Copenhagen) discusses a trial of liraglutide versus colesevelam for the treatment of bile acid diarrhoea.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00198-4/fulltext'>Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Filip Knop (University of Copenhagen) discusses a trial of liraglutide versus colesevelam for the treatment of bile acid diarrhoea.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00198-4/fulltext'>Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pezjvp8y8wfyksc2/1728646_episodes_11237448-filip-knop-on-liraglutide-for-bile-acid-diarrhoea.mp3" length="10854497" type="audio/mpeg"/>
        <itunes:summary>Filip Knop (University of Copenhagen) discusses a trial of liraglutide versus colesevelam for the treatment of bile acid diarrhoea.  Read the full article: Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https:...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>902</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinoma</title>
        <itunes:title>Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinoma</itunes:title>
        <link>https://lancetgastro.podbean.com/e/edward-kim-on-radiation-segmentectomy-for-unresectable-very-early-to-early-stage-hepatocellular-carcinoma/</link>
                    <comments>https://lancetgastro.podbean.com/e/edward-kim-on-radiation-segmentectomy-for-unresectable-very-early-to-early-stage-hepatocellular-carcinoma/#comments</comments>        <pubDate>Thu, 04 Aug 2022 13:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-11081301</guid>
                                    <description><![CDATA[<p>Edward Kim (Icahn School of Medicine at Mount Sinai) discusses the single-arm RASER study of radiation segmentectomy for patients with unresectable very early to early stage hepatocellular carcinoma.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00091-7/fulltext'>Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Edward Kim (Icahn School of Medicine at Mount Sinai) discusses the single-arm RASER study of radiation segmentectomy for patients with unresectable very early to early stage hepatocellular carcinoma.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00091-7/fulltext'>Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/01z3ijn82pg3w0dh/1728646_episodes_11081301-edward-kim-on-radiation-segmentectomy-for-unresectable-very-early-to-early-stage-hepatocellular-carcinoma.mp3" length="10194339" type="audio/mpeg"/>
        <itunes:summary>Edward Kim (Icahn School of Medicine at Mount Sinai) discusses the single-arm RASER study of radiation segmentectomy for patients with unresectable very early to early stage hepatocellular carcinoma.  Read the full article: Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  htt...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>846</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Joep Ijspeert on serrated polyp detection and risk of interval post-colonoscopy colorectal cancer</title>
        <itunes:title>Joep Ijspeert on serrated polyp detection and risk of interval post-colonoscopy colorectal cancer</itunes:title>
        <link>https://lancetgastro.podbean.com/e/joep-ijspeert-on-serrated-polyp-detection-and-risk-of-interval-post-colonoscopy-colorectal-cancer/</link>
                    <comments>https://lancetgastro.podbean.com/e/joep-ijspeert-on-serrated-polyp-detection-and-risk-of-interval-post-colonoscopy-colorectal-cancer/#comments</comments>        <pubDate>Wed, 06 Jul 2022 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-10913969</guid>
                                    <description><![CDATA[<p>Joep Ijspeert (Amsterdam University Medical Center) discusses a population-based study exploring the detection of proximal serrated polyps and interval post-colonoscopy colorectal cancer risk.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00090-5/fulltext'>Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: a population-based study</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Joep Ijspeert (Amsterdam University Medical Center) discusses a population-based study exploring the detection of proximal serrated polyps and interval post-colonoscopy colorectal cancer risk.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00090-5/fulltext'>Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: a population-based study</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hb4pz75pq2n5gmrx/1728646_episodes_10913969-joep-ijspeert-on-serrated-polyp-detection-and-risk-of-interval-post-colonoscopy-colorectal-cancer.mp3" length="7557895" type="audio/mpeg"/>
        <itunes:summary>Joep Ijspeert (Amsterdam University Medical Center) discusses a population-based study exploring the detection of proximal serrated polyps and interval post-colonoscopy colorectal cancer risk.  Read the full article: Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: a population-based study Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://inst...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>626</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulas</title>
        <itunes:title>Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulas</itunes:title>
        <link>https://lancetgastro.podbean.com/e/elise-meima-van-praag-on-surgical-closure-for-crohn-s-disease-perianal-fistulas/</link>
                    <comments>https://lancetgastro.podbean.com/e/elise-meima-van-praag-on-surgical-closure-for-crohn-s-disease-perianal-fistulas/#comments</comments>        <pubDate>Tue, 14 Jun 2022 15:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-10791546</guid>
                                    <description><![CDATA[<p>Elise Meima-van Praag (Amsterdam University Medical Centre) discusses the PISA-II trial, investigating short-term anti-TNF therapy with surgical closure versus anti-TNF therapy for perianal fistulas in Crohn's disease.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00088-7/fulltext'>Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II)</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Elise Meima-van Praag (Amsterdam University Medical Centre) discusses the PISA-II trial, investigating short-term anti-TNF therapy with surgical closure versus anti-TNF therapy for perianal fistulas in Crohn's disease.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00088-7/fulltext'>Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II)</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cc7ablzbz670duvv/1728646_episodes_10791546-elise-meima-van-praag-on-surgical-closure-for-crohn-s-disease-perianal-fistulas.mp3" length="7120707" type="audio/mpeg"/>
        <itunes:summary>Elise Meima-van Praag (Amsterdam University Medical Centre) discusses the PISA-II trial, investigating short-term anti-TNF therapy with surgical closure versus anti-TNF therapy for perianal fistulas in Crohn's disease.  Read the full article: Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II) Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.socia...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>590</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Juan Pablo Arab on NAFLD public health policies in the Americas</title>
        <itunes:title>Juan Pablo Arab on NAFLD public health policies in the Americas</itunes:title>
        <link>https://lancetgastro.podbean.com/e/juan-pablo-arab-on-nafld-public-health-policies-in-the-americas/</link>
                    <comments>https://lancetgastro.podbean.com/e/juan-pablo-arab-on-nafld-public-health-policies-in-the-americas/#comments</comments>        <pubDate>Mon, 09 May 2022 09:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-10591403</guid>
                                    <description><![CDATA[<p>Juan Pablo Arab (Catholic University of Chile) discusses the current burden of NAFLD and the landscape of public health policies related to the disease in the Americas.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00008-5/fulltext'>The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Juan Pablo Arab (Catholic University of Chile) discusses the current burden of NAFLD and the landscape of public health policies related to the disease in the Americas.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00008-5/fulltext'>The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5tahr9umcwhwex9n/1728646_episodes_10591403-juan-pablo-arab-on-nafld-public-health-policies-in-the-americas.mp3" length="12341624" type="audio/mpeg"/>
        <itunes:summary>Juan Pablo Arab (Catholic University of Chile) discusses the current burden of NAFLD and the landscape of public health policies related to the disease in the Americas.  Read the full article: The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com/thelancet...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1026</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sarah Blach on hepatitis C virus epidemiology</title>
        <itunes:title>Sarah Blach on hepatitis C virus epidemiology</itunes:title>
        <link>https://lancetgastro.podbean.com/e/sarah-blach-on-hepatitis-c-virus-epidemiology/</link>
                    <comments>https://lancetgastro.podbean.com/e/sarah-blach-on-hepatitis-c-virus-epidemiology/#comments</comments>        <pubDate>Wed, 06 Apr 2022 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-10390040</guid>
                                    <description><![CDATA[<p>Sarah Blach (CDA Foundation) summarises the latest analysis of global hepatitis C virus epidemiology and cascade of care by the Polaris Observatory HCV Collaborators.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00472-6/fulltext'>Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Sarah Blach (CDA Foundation) summarises the latest analysis of global hepatitis C virus epidemiology and cascade of care by the Polaris Observatory HCV Collaborators.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00472-6/fulltext'>Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rx0pldfjt7hs0sbt/1728646_episodes_10390040-sarah-blach-on-hepatitis-c-virus-epidemiology.mp3" length="6479907" type="audio/mpeg"/>
        <itunes:summary>Sarah Blach (CDA Foundation) summarises the latest analysis of global hepatitis C virus epidemiology and cascade of care by the Polaris Observatory HCV Collaborators.  Read the full article: Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com/thelancetgroup  ...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>537</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sunil Solomon on a minimal monitoring approach for hepatitis C virus infection</title>
        <itunes:title>Sunil Solomon on a minimal monitoring approach for hepatitis C virus infection</itunes:title>
        <link>https://lancetgastro.podbean.com/e/sunil-solomon-on-a-minimal-monitoring-approach-for-hepatitis-c-virus-infection/</link>
                    <comments>https://lancetgastro.podbean.com/e/sunil-solomon-on-a-minimal-monitoring-approach-for-hepatitis-c-virus-infection/#comments</comments>        <pubDate>Wed, 23 Mar 2022 10:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-10302346</guid>
                                    <description><![CDATA[<p>Sunil Solomon (Johns Hopkins University) discusses a study of a minimal monitoring approach for treating patients with hepatitis C virus infection.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00397-6/fulltext'>A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Sunil Solomon (Johns Hopkins University) discusses a study of a minimal monitoring approach for treating patients with hepatitis C virus infection.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00397-6/fulltext'>A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bnd00p1pacb6jbkt/1728646_episodes_10302346-sunil-solomon-on-a-minimal-monitoring-approach-for-hepatitis-c-virus-infection.mp3" length="10867272" type="audio/mpeg"/>
        <itunes:summary>Sunil Solomon (Johns Hopkins University) discusses a study of a minimal monitoring approach for treating patients with hepatitis C virus infection.  Read the full article: A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com/...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>902</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Rupert Leong on oral faecal microbiota transplantation in ulcerative colitis</title>
        <itunes:title>Rupert Leong on oral faecal microbiota transplantation in ulcerative colitis</itunes:title>
        <link>https://lancetgastro.podbean.com/e/rupert-leong-on-oral-faecal-microbiota-transplantation-in-ulcerative-colitis/</link>
                    <comments>https://lancetgastro.podbean.com/e/rupert-leong-on-oral-faecal-microbiota-transplantation-in-ulcerative-colitis/#comments</comments>        <pubDate>Wed, 09 Mar 2022 12:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-10217270</guid>
                                    <description><![CDATA[<p>Rupert Leong (University of Sydney) discusses a new double-blind, randomised, placebo-controlled trial of oral faecal microbiota transplantation for patients with active ulcerative colitis.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00400-3/fulltext'>Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS)</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Rupert Leong (University of Sydney) discusses a new double-blind, randomised, placebo-controlled trial of oral faecal microbiota transplantation for patients with active ulcerative colitis.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00400-3/fulltext'>Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS)</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ykv5lcy7gywt5b20/1728646_episodes_10217270-rupert-leong-on-oral-faecal-microbiota-transplantation-in-ulcerative-colitis.mp3" length="9912575" type="audio/mpeg"/>
        <itunes:summary>Rupert Leong (University of Sydney) discusses a new double-blind, randomised, placebo-controlled trial of oral faecal microbiota transplantation for patients with active ulcerative colitis.  Read the full article: Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS) Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com/thelancetgroup  ht...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>823</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Swati Patel on early-onset colorectal cancer</title>
        <itunes:title>Swati Patel on early-onset colorectal cancer</itunes:title>
        <link>https://lancetgastro.podbean.com/e/swati-patel-on-early-onset-colorectal-cancer/</link>
                    <comments>https://lancetgastro.podbean.com/e/swati-patel-on-early-onset-colorectal-cancer/#comments</comments>        <pubDate>Wed, 09 Feb 2022 23:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-10036331</guid>
                                    <description><![CDATA[<p>Swati Patel (University of Colorado Anschutz Medical Center) discusses the epidemiology, clinical features, biology, risk factors, and opportunities for prevention and detection of early-onset colorectal cancers.

Read the full article:
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00426-X/fulltext'>The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Swati Patel (University of Colorado Anschutz Medical Center) discusses the epidemiology, clinical features, biology, risk factors, and opportunities for prevention and detection of early-onset colorectal cancers.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00426-X/fulltext'>The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection</a></p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4ybw7re3t15mx4ro/1728646_episodes_10036331-swati-patel-on-early-onset-colorectal-cancer.mp3" length="14044038" type="audio/mpeg"/>
        <itunes:summary>Swati Patel (University of Colorado Anschutz Medical Center) discusses the epidemiology, clinical features, biology, risk factors, and opportunities for prevention and detection of early-onset colorectal cancers.  Read the full article: The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgas...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1167</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Emilie Breekveldt on FIT-based screening for colorectal cancer in the Netherlands</title>
        <itunes:title>Emilie Breekveldt on FIT-based screening for colorectal cancer in the Netherlands</itunes:title>
        <link>https://lancetgastro.podbean.com/e/emilie-breekveldt-on-fit-based-screening-for-colorectal-cancer-in-the-netherlands/</link>
                    <comments>https://lancetgastro.podbean.com/e/emilie-breekveldt-on-fit-based-screening-for-colorectal-cancer-in-the-netherlands/#comments</comments>        <pubDate>Fri, 10 Dec 2021 12:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-9697263</guid>
                                    <description><![CDATA[<p>Emilie Breekveldt (Erasmus Medical Center, Netherlands) discusses a new analysis of the faecal immunochemical testing-based colorectal screening programme in the Netherlands. 

Read the full article:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00368-X/fulltext</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Emilie Breekveldt (Erasmus Medical Center, Netherlands) discusses a new analysis of the faecal immunochemical testing-based colorectal screening programme in the Netherlands. <br>
<br>
Read the full article:<br>
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00368-X/fulltext</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yipbpy2yon2zg7dy/1728646_episodes_9697263-emilie-breekveldt-on-fit-based-screening-for-colorectal-cancer-in-the-netherlands.mp3" length="6982137" type="audio/mpeg"/>
        <itunes:summary>Emilie Breekveldt (Erasmus Medical Center, Netherlands) discusses a new analysis of the faecal immunochemical testing-based colorectal screening programme in the Netherlands.   Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00368-X/fulltext Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com/thelancetgroup  https://f...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>579</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Wendy Spearman on non-alcoholic fatty liver disease in sub-Saharan Africa</title>
        <itunes:title>Wendy Spearman on non-alcoholic fatty liver disease in sub-Saharan Africa</itunes:title>
        <link>https://lancetgastro.podbean.com/e/wendy-spearman-on-non-alcoholic-fatty-liver-disease-in-sub-saharan-africa/</link>
                    <comments>https://lancetgastro.podbean.com/e/wendy-spearman-on-non-alcoholic-fatty-liver-disease-in-sub-saharan-africa/#comments</comments>        <pubDate>Thu, 11 Nov 2021 23:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-9525235</guid>
                                    <description><![CDATA[<p>Wendy Spearman (University of Cape Town) discusses a Series on the emergence of non-alcoholic fatty liver disease in Sub-Saharan Africa and the challenges it presents.

Read the full article:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00296-X/fulltext</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Wendy Spearman (University of Cape Town) discusses a Series on the emergence of non-alcoholic fatty liver disease in Sub-Saharan Africa and the challenges it presents.<br>
<br>
Read the full article:<br>
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00296-X/fulltext</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/somdndypib0330eb/1728646_episodes_9525235-wendy-spearman-on-non-alcoholic-fatty-liver-disease-in-sub-saharan-africa.mp3" length="16289341" type="audio/mpeg"/>
        <itunes:summary>Wendy Spearman (University of Cape Town) discusses a Series on the emergence of non-alcoholic fatty liver disease in Sub-Saharan Africa and the challenges it presents.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00296-X/fulltext Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com/thelancetgroup  https://facebook.com/t...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1354</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Tim Vanuytsel on spore-forming probiotics in functional dyspepsia</title>
        <itunes:title>Tim Vanuytsel on spore-forming probiotics in functional dyspepsia</itunes:title>
        <link>https://lancetgastro.podbean.com/e/tim-vanuytsel-on-spore-forming-probiotics-in-functional-dyspepsia/</link>
                    <comments>https://lancetgastro.podbean.com/e/tim-vanuytsel-on-spore-forming-probiotics-in-functional-dyspepsia/#comments</comments>        <pubDate>Thu, 09 Sep 2021 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-9165948</guid>
                                    <description><![CDATA[<p>Tim Vanuytsel (University of Leuven) discusses a new trial of spore-forming probiotics in functional dyspepsia.

Read the full article:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00226-0/fulltext</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Tim Vanuytsel (University of Leuven) discusses a new trial of spore-forming probiotics in functional dyspepsia.<br>
<br>
Read the full article:<br>
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00226-0/fulltext</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8yo4mahpjaswn37f/1728646_episodes_9165948-tim-vanuytsel-on-spore-forming-probiotics-in-functional-dyspepsia.mp3" length="5102184" type="audio/mpeg"/>
        <itunes:summary>Tim Vanuytsel (University of Leuven) discusses a new trial of spore-forming probiotics in functional dyspepsia.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00226-0/fulltext Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com/thelancetgroup  https://facebook.com/thelancetmedicaljournal  https://youtube.com/thelancettv</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>422</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Raymond Henderson on the economic burden of colorectal cancer</title>
        <itunes:title>Raymond Henderson on the economic burden of colorectal cancer</itunes:title>
        <link>https://lancetgastro.podbean.com/e/raymond-henderson-on-the-economic-burden-of-colorectal-cancer/</link>
                    <comments>https://lancetgastro.podbean.com/e/raymond-henderson-on-the-economic-burden-of-colorectal-cancer/#comments</comments>        <pubDate>Thu, 12 Aug 2021 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-8998217</guid>
                                    <description><![CDATA[<p>Raymond Henderson (Queen’s University Belfast) discusses a new analysis of the economic burden of colorectal cancer in Europe.

Read the full article:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00147-3/fulltext</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Raymond Henderson (Queen’s University Belfast) discusses a new analysis of the economic burden of colorectal cancer in Europe.<br>
<br>
Read the full article:<br>
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00147-3/fulltext</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ds1pkuble2vlzyxt/1728646_episodes_8998217-raymond-henderson-on-the-economic-burden-of-colorectal-cancer.mp3" length="8203394" type="audio/mpeg"/>
        <itunes:summary>Raymond Henderson (Queen’s University Belfast) discusses a new analysis of the economic burden of colorectal cancer in Europe.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00147-3/fulltext Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com/thelancetgroup  https://facebook.com/thelancetmedicaljournal  https://youtube.c...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>680</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sigurður Ólafsson on eliminating hepatitis C in Iceland</title>
        <itunes:title>Sigurður Ólafsson on eliminating hepatitis C in Iceland</itunes:title>
        <link>https://lancetgastro.podbean.com/e/sigur%c3%b0ur-olafsson-on-eliminating-hepatitis-c-in-iceland/</link>
                    <comments>https://lancetgastro.podbean.com/e/sigur%c3%b0ur-olafsson-on-eliminating-hepatitis-c-in-iceland/#comments</comments>        <pubDate>Tue, 22 Jun 2021 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-8743925</guid>
                                    <description><![CDATA[<p>Sigurður Ólafsson (Landspitali University Hospital) discusses newly published results from the nationwide programme to eliminate hepatitis C virus in Iceland. 

Read the full article:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00137-0/fulltext</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Sigurður Ólafsson (Landspitali University Hospital) discusses newly published results from the nationwide programme to eliminate hepatitis C virus in Iceland. <br>
<br>
Read the full article:<br>
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00137-0/fulltext</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/16q0lkpdtbel3lhq/1728646_episodes_8743925-sigurdur-olafsson-on-eliminating-hepatitis-c-in-iceland.mp3" length="9506590" type="audio/mpeg"/>
        <itunes:summary>Sigurður Ólafsson (Landspitali University Hospital) discusses newly published results from the nationwide programme to eliminate hepatitis C virus in Iceland.   Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00137-0/fulltext Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com/thelancetgroup  https://facebook.com/thel...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>789</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Caroline Ovadia on intrahepatic cholestasis of pregnancy</title>
        <itunes:title>Caroline Ovadia on intrahepatic cholestasis of pregnancy</itunes:title>
        <link>https://lancetgastro.podbean.com/e/caroline-ovadia-on-intrahepatic-cholestasis-of-pregnancy/</link>
                    <comments>https://lancetgastro.podbean.com/e/caroline-ovadia-on-intrahepatic-cholestasis-of-pregnancy/#comments</comments>        <pubDate>Thu, 03 Jun 2021 09:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-8636587</guid>
                                    <description><![CDATA[<p>Caroline Ovadia (King’s College London) discusses an individual participant data meta-analysis on the treatment of intrahepatic cholestasis of pregnancy with ursodeoxycholic acid.

Read the full article:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00074-1/fulltext</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Caroline Ovadia (King’s College London) discusses an individual participant data meta-analysis on the treatment of intrahepatic cholestasis of pregnancy with ursodeoxycholic acid.<br>
<br>
Read the full article:<br>
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00074-1/fulltext</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2f7wv7nuzcixssy3/1728646_episodes_8636587-caroline-ovadia-on-intrahepatic-cholestasis-of-pregnancy.mp3" length="8979337" type="audio/mpeg"/>
        <itunes:summary>Caroline Ovadia (King’s College London) discusses an individual participant data meta-analysis on the treatment of intrahepatic cholestasis of pregnancy with ursodeoxycholic acid.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00074-1/fulltext Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com/thelancetgroup  https://fa...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>745</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Matthew Akiyama on hepatitis C in prisons</title>
        <itunes:title>Matthew Akiyama on hepatitis C in prisons</itunes:title>
        <link>https://lancetgastro.podbean.com/e/matthew-akiyama-on-hepatitis-c-in-prisons/</link>
                    <comments>https://lancetgastro.podbean.com/e/matthew-akiyama-on-hepatitis-c-in-prisons/#comments</comments>        <pubDate>Mon, 12 Apr 2021 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-8317970</guid>
                                    <description><![CDATA[<p>Matthew Akiyama (Montefiore Medical Center and Albert Einstein College of Medicine, USA) discusses a Review on hepatitis C elimination among people incarcerated in prisons.

Read the full article:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(20)30365-4/fulltext</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Matthew Akiyama (Montefiore Medical Center and Albert Einstein College of Medicine, USA) discusses a Review on hepatitis C elimination among people incarcerated in prisons.<br>
<br>
Read the full article:<br>
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(20)30365-4/fulltext</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/112bkiny9ae9gbbg/1728646_episodes_8317970-matthew-akiyama-on-hepatitis-c-in-prisons.mp3" length="5155173" type="audio/mpeg"/>
        <itunes:summary>Matthew Akiyama (Montefiore Medical Center and Albert Einstein College of Medicine, USA) discusses a Review on hepatitis C elimination among people incarcerated in prisons.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(20)30365-4/fulltext Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com/thelancetgroup  https://facebook....</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>426</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Monika Sarkar on reproductive health in women with liver disease</title>
        <itunes:title>Monika Sarkar on reproductive health in women with liver disease</itunes:title>
        <link>https://lancetgastro.podbean.com/e/monika-sarkar-on-reproductive-health-in-women-with-liver-disease/</link>
                    <comments>https://lancetgastro.podbean.com/e/monika-sarkar-on-reproductive-health-in-women-with-liver-disease/#comments</comments>        <pubDate>Thu, 11 Mar 2021 23:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-8107604</guid>
                                    <description><![CDATA[<p>Monika Sarkar (University of California San Francisco, USA) discusses her Comment on reproductive health in women with chronic liver disease.

Read the full article:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00055-8/fulltext</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a>

Follow us today at...
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Monika Sarkar (University of California San Francisco, USA) discusses her Comment on reproductive health in women with chronic liver disease.<br>
<br>
Read the full article:<br>
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00055-8/fulltext</p>
<p>Continue this conversation on social!</p>
 <p>Follow us today at...</p>
 <p><a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>https://bsky.app/profile/lancetgastrohep.bsky.social</a></p>
 <p><a href='https://www.linkedin.com/company/langastro/'>https://www.linkedin.com/company/langastro/</a></p>
 <p><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a></p>
 <p><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a></p>
 <p><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Gastroenterology &amp; Hepatology in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/langas/home'>https://www.thelancet.com/</a><br>
<br>
Follow us today at...<br>
<a href='https://x.com/LancetGastroHep?lang=en'>x.com/LancetGastroHep</a><br>
<a href='https://bsky.app/profile/lancetgastrohep.bsky.social'>bsky.app/lancetgastrohep.bsky.social</a><br>
 <a href='https://www.linkedin.com/company/105999114/admin/dashboard/'>Linkedin.com</a><br>
<a href='https://www.instagram.com/thelancetgroup'>Instagram</a><br>
<a href='https://www.facebook.com/TheLancetMedicalJournal/'>Facebook</a><br>
<a href='https://www.youtube.com/thelancettv'>youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4x0w5z0i5suy7tkw/1728646_episodes_8107604-monika-sarkar-on-reproductive-health-in-women-with-liver-disease.mp3" length="5976013" type="audio/mpeg"/>
        <itunes:summary>Monika Sarkar (University of California San Francisco, USA) discusses her Comment on reproductive health in women with chronic liver disease.  Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00055-8/fulltext Continue this conversation on social!  Follow us today at...  https://bsky.app/profile/lancetgastrohep.bsky.social  https://www.linkedin.com/company/langastro/  https://instagram.com/thelancetgroup  https://facebook.com/thelancetmedicaljournal  ht...</itunes:summary>
        <itunes:author>The Lancet Gastroenterology &amp;amp; Hepatology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>495</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
</channel>
</rss>
